Drug Development

Articles

In a goal to boost local pharmaceutical production, the World Health Organization has established a global manufacturing training hub in the Republic of Korea through which Bangladesh, Indonesia, Pakistan, Serbia, and Vietnam will receive mRNA technology.

WHO Establishes Global Biomanufacturing Training Hub in Republic of Korea

Under a collaboration, IDT Biologika and Exothera will conduct feasibility studies on scaling up the manufacturing process for viral vector-based vaccines.

IDT Biologika and Exothera Partner on Viral Vaccines Manufacturing

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Technological advances are helping shape the dosage forms of the future.

The Shape of Dosage Forms

Developers need to consider key challenges when approaching accelerated formulation strategies to ensure success.

Successfully Accelerating Formulation Strategies

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Bacteriophages could be crucial weapons in the fight against antibiotic-resistant bacteria.

The State of Phage Therapy 

Pfizer has received Breakthrough Therapy Designation from FDA for its RSV vaccine candidate for prevention of RSV illness in infants by active immunization of pregnant women.

Pfizer Receives FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus Vaccine Candidate

Biocon Biologics will acquire Viatris’ global biosimilars business, including the company’s portfolio of in-licensed biosimilar assets, in a transaction valued at over $3.3 billion.

Biocon Biologics to Acquire Biosimilars Assets from Viatris in $3.3 Billion Deal

BioMed X and Boehringer Ingelheim have announced the start of a new research project in brain sensor development. 

BioMed X Institute and Boehringer Ingelheim Start New Research Project in Brain Sensor Development

EMA has recommended approval of Spikevax for children aged 6 to 11.

EMA Recommends Approval of Spikevax for Children Aged 6 to 11

AstraZeneca and Honeywell will partner to develop next-generation respiratory inhalers as part of AstraZeneca’s Ambition Zero Carbon program. 

Formulation and Drug Delivery